24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Direct Offering
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:50
Deel strikes multi-year deal with Arsenal as tech firm enters global sport
13:57
Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or
21:53
Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters
15:12
Palo Alto Networks: Hamas-linked hackers launch stealth espionage push across Arab governments
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.
2
Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters
3
After over $390 million in funding, Believer Meats abruptly shuts down
4
Israel’s quantum boom: Startups hit $500 million in funding in 2025
5
BlackRock in talks for major investment in creative-tech firm Artlist
More news
Direct Offering
4 stories about Direct Offering
Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering
10.07.18
|
CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering
17.06.18
|
Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Liver Treatment Company Galmed is Raising $6 Million in Direct Offering
04.04.18
|
Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014